hum0127 Release Note
| Research ID | Release Date | Type of Data |
|---|---|---|
| hum0127.v4 | 2024/07/10 | NGS (WGS) |
| hum0127.v3 | 2024/01/22 | NGS (WGS), Microarray, Methylation array |
| hum0127.v2 | 2021/03/08 | NGS (Exome, DNA Amplicon-seq, RNA Amplicon-seq), Microarray |
| hum0127.v1 | 2020/04/14 | NGS (Exome) |
hum0127.v4
DNAs extracted from peripheral blood cells (non-tumor cells) and surgically dissected tumor and non-tumor tissues from 177 cancer patients in which no changes in driver genes were detected by whole exon sequencing and whole gene expression analysis were used for whole genome sequencing analysis. Variant information was provided only in the tumor tissues (tab, vcf). Whole Genome Sequencing was performed using NovaSeq 6000 (Illumina).
hum0127.v3
DNAs and RNAs extracted from peripheral blood cells (non-tumor cells) and surgically dissected tumor and non-tumor tissues from 30 gastrointestinal stromal tumor (GIST) patients were used for whole genome sequencing analysis (vcf), Microarray analysis (gene expression profiling: text), and methylation array analysis (idat). Whole Genome Sequencing was performed using NovaSeq 6000 (Illumina). Gene expression profiling was performed by using of SurePrint G3 Human GE v2 8x60K Microarray (Agilent Technologies). DNA methylation array were performed using Infinium MethylationEPIC array and iScan System (Illumina).
hum0127.v2
DNAs and RNAs extracted from white blood cells (non-tumor tissues) and surgically dissected tumor and non-tumor tissues from 5143 cancer patients were used for whole exome sequencing analysis (vcf, tab), DNA amplicon sequencing analysis (vcf), and RNA amplicon sequencing analysis (tab). Sequencing were performed using Ion Proton (Thermo Fisher Scientific). Microarray analysis (tab) was performed by using of SurePrint G3 Human Gene Expression 8 × 60 K v2 Microarray (Agilent Technologies).
hum0127.v1
DNAs extracted from blood cells (non-tumor tissues) and surgically dissected tumor tissues from 91 cancer patients with hypermutator tumors harborig POLE mutations were used for whole exome sequencing analysis. Variant information only in the tumor tissues was provided (vcf files). Sequencing were performed using Ion Proton (Thermo Fisher Scientific).
Note:
